SCHEMBL6201975

SCHEMBL6201975

COC(=O)c1cccc(Oc2cccnc2)c1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.64
LMNA P02545 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.56
CYP19A1 P11511 1/20 0.56
CYP11B1 P15538 1/20 0.56
CYP11B2 P19099 1/20 0.56
KDM4E B2RXH2 2/20 0.55
USP2 O75604 1/20 0.55
ALOX15 P16050 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
MEN1 O00255 1/20 0.52
GAA P10253 1/20 0.52
MAPK1 P28482 1/20 0.52
KMT2A Q03164 1/20 0.52
GRM5 P41594 1/20 0.52
NEK1 Q96PY6 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2436534 0.86 L3MBTL1 (0.65) ALDH1A1L3MBTL1MEN1MAPK1KMT2A
SCHEMBL27530951 0.85 ALDH1A1 (0.70) ALDH1A1CYP19A1CYP11B1CYP11B2KDM4E
SCHEMBL3530054 0.85 KMT2A (0.64) ALDH1A1LMNATDP1CYP19A1CYP11B1
SCHEMBL6243390 0.85 L3MBTL1 (0.58) ALDH1A1LMNAL3MBTL1KDM4EMEN1
SCHEMBL1984609 0.83 AKR1C3 (0.67) ALDH1A1LMNATDP1KDM4EGAA
SCHEMBL1399775 0.82 CYP19A1 (0.74) ALDH1A1CYP19A1CYP11B1CYP11B2KDM4E
SCHEMBL6202616 0.82 LMNA (0.64) ALDH1A1LMNATDP1CYP19A1KDM4E
Hydrochloric Acid SCHEMBL6202981 0.82 AKR1C3 (0.65) ALDH1A1LMNATDP1KDM4EGAA
SCHEMBL7765921 0.81 TDP1 (0.54) ALDH1A1LMNATDP1CYP19A1GAA
SCHEMBL521860 0.81 AKR1C3 (0.68) ALDH1A1LMNAL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208104-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMA (US) 2005-01-19 EP disclosed
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 US disclosed
EP-1208104-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2002-05-29 EP disclosed
WO-2001016136-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2001-03-08 WO disclosed